Xanthine oxidase (XOD) is an important target for routine treatment of hyperuricemia (39), and inhibiting XOD activity could prevent the conversion of xanthine to UA, so that stronger XOD activity causes higher UA levels. Here, XDH is linked to hyperuricemia.